Robert Byrne and C. Michael Gibson discuss a randomized trial of a thromboresistant Polyzene F-coated stent with 14-day DAPT in high-bleeding-risk patients.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
